What is Discovery and development of nucleoside and nucleotide reverse-transcriptase inhibitors?

Discovery and development of nucleoside and nucleotide reverse-transcriptase inhibitors began in the 1980s when the AIDS epidemic hit Western societies. NRTIs inhibit the reverse transcriptase , an enzyme that controls the replication of the genetic material of the human immunodeficiency virus. The first NRTI was zidovudine, approved by the U.S. Food and Drug Administration in 1987, which was the first step towards treatment of HIV. Six NRTI agents and one NtRTI have followed. The NRTIs and the NtRTI are analogues of endogenous 2´-deoxy-nucleoside and nucleotide. Drug-resistant viruses are an inevitable consequence of prolonged exposure of HIV-1 to anti-HIV drugs.